P01.11 New targets for glioblastoma revealed by chemical biology fingerprinting

Introduction: Glioblastoma multiforme (GBM) is a particularly aggressive brain cancer with extremely inadequate treatment options. Even with resection, ionizing radiation and use of the alkylating agent temozolomide the median survival is only 14.3 months. Therefore, there is a great need for novel...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Finlay, D., Dhruv, H., Hauser, C., Kiefer, J., Kim, S., Long, T., Peng, S., Speyer, G., Berens, M., Vuori, K.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
POSTER PRESENTATIONS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463694/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.087
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki